TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Navamedic ASA
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
515,308
|
505,411
|
403,985 |
| Financial expenses |
47,224
|
14,153
|
13,382 |
| Earnings before taxes |
-1,571
|
10,694
|
44,935 |
| Total assets |
453,290
|
517,560
|
404,659 |
| Current assets |
193,927
|
207,415
|
257,465 |
| Current liabilities |
136,544
|
186,848
|
133,269 |
| Equity capital |
210,097
|
219,531
|
221,712 |
| - share capital |
12,673
|
12,677
|
13,478 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
46.3%
|
42.4%
|
54.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-0.3%
|
2.1%
|
11.1% |
| Return on assets (ROA) |
10.1%
|
4.8%
|
14.4% |
| Current ratio |
142.0%
|
111.0%
|
193.2% |
| Return on equity (ROE) |
-0.7%
|
4.9%
|
20.3% |
| Change turnover |
18,849
|
128,191
|
109,625 |
| Change turnover % |
4%
|
34%
|
37% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.